Cargando…

The frequency of bowel and bladder problems in multiple sclerosis and its relation to fatigue: A single centre experience

BACKGROUND: Bowel and bladder problems affect more than 50% of people with Multiple Sclerosis (MS). These problems have a large impact on quality of life and place a significant burden on health systems. OBJECTIVES: This study aimed to ascertain the frequency of bladder and bowel problems in a selec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Sophia D., Butler, Jane E., Boswell-Ruys, Claire L., Hoang, Phu, Jarvis, Tom, Gandevia, Simon C., McCaughey, Euan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752850/
https://www.ncbi.nlm.nih.gov/pubmed/31536557
http://dx.doi.org/10.1371/journal.pone.0222731
Descripción
Sumario:BACKGROUND: Bowel and bladder problems affect more than 50% of people with Multiple Sclerosis (MS). These problems have a large impact on quality of life and place a significant burden on health systems. OBJECTIVES: This study aimed to ascertain the frequency of bladder and bowel problems in a select Australian MS cohort and to investigate the relationships between level of disability, bladder and bowel problems, and fatigue. METHODS: Questionnaires on the nature and severity of MS symptoms were distributed to clients attending an Australian MS centre. Log-binomial regression and multiple linear regression models were used to investigate relationships between disability, fatigue, and bladder and bowel problems. RESULTS AND CONCLUSIONS: Of 167 questionnaires distributed, 136 were completed. Bladder problems were reported by 87 (74.4%) respondents, whilst 66 (48.9%) experienced functional constipation and 43 (31.9%) faecal incontinence. This frequency in our select Australian MS population is similar to that reported globally. There was a significant correlation between level of disability and: bladder problems (p = 0.015), faecal incontinence (p = 0.001), fatigue (p<0.001) and constipation (p = 0.016, relative risk: 1.16). Further investigation into the causal relationships between various MS symptoms may be beneficial in the development of novel therapeutic strategies for people with MS.